Critical Care Diagnostics Market

Report Description
Table of Contents

Report Description

The global critical care diagnostics market size is estimated to be USD xx billion in 2021 and is anticipated to witness a CAGR of xx% during the forecast period. Growth in demand from patient for rapid diagnosis and treatment for various diseases is a key driver for the growth of the global critical care diagnostics market. Additionally, increase in aged population and remote communications and telehealth amid diagnostics and laboratories are some of the other drivers propelling the market growth. Nevertheless, high cost of critical care diagnostics treatment and shortage of skilled labour are expected to restrain the global market growth.

Global Critical Care Diagnostics Market Size (USD Billion), 2021-2029

Source: Erevna Healthcare

By Type

Based on type, the market is segmented into coagulation, routine and special chemistry, haematology, immunoproteins, flow cytometry, microbial and infectious test, and others. In 2021, the immunoproteins segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to rising demand for rapid and precise early diagnosis along with the ability to decrease the recovery time of patients worldwide. Haematology segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the advanced technologies available for haematology analysis and growth in the number of blood donations.

By End User

Based on end user, the market is segmented into intensive care units, operating rooms, emergency rooms, and others. In 2021, the emergency rooms segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to increase in survival ratio of critically ill patients admitted to the emergency department is directly linked to the advancement of initial diagnosis and treatment of diseases worldwide. Intensive care units segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the rise in the burden of injuries occurring because of increasing accidents and chronic diseases owed to global ageing population.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of major players in the region, increase in the number of road accidents, growth in initiatives from government, accessibility of technological advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the rise in chronic diseases, growing government and private investment in healthcare sector, rise geriatric population in countries such as China, Japan, and India, and availability of skilled labour forces at economic costs, are the major factors in this region.

Competitor Insights

Some of the key players in the critical care diagnostics market are Abbott Laboratories (U.S.); Alere Inc. (U.S.); Danaher Corporation (U.S.); F. Hoffmann-La Roche AG (Switzerland); Becton, Dickinson and Company (U.S.); EKF Diagnostics (U.K.); BioMerieux, SA (France); Siemens Healthineers AG (Germany); Chembio Diagnostic Systems, Inc. (U.S.); and Bayer Healthcare AG (Germany). The leading players operating in the critical care diagnostics industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The critical care diagnostics market report is categorized into the following segments and subsegments: